Edition:
United States

NexgenRx Inc (NXG.V)

NXG.V on TSX Venture Exchange

0.28CAD
--
Change (% chg)

-- (--)
Prev Close
$0.28
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
36,624
52-wk High
$0.35
52-wk Low
$0.15

Latest Key Developments (Source: Significant Developments)

NexgenRx says Kelly Ehler appointed interim CFO
Monday, 5 Dec 2016 05:03pm EST 

NexgenRx Inc : NexgenRx announces cfo changes . Says Kelly Ehler appointed interim CFO .Taba Merrikh has stepped down as CFO.  Full Article

Nexgenrx Qtrly loss per share $0.175
Monday, 14 Nov 2016 05:25pm EST 

Nexgenrx Inc : Q3 revenue C$1.397 million .Nexgenrx announces Q3 2016 results.  Full Article

Nexgenrx announces Q2 revenue of C$1.57 mln
Wednesday, 27 Jul 2016 04:39pm EDT 

Nexgenrx Inc : Nexgenrx announces Q2 2016 results .Q2 revenue C$1.57 million.  Full Article

NexgenRx announces completion of $550,000 unit financing
Tuesday, 30 Jun 2015 05:39pm EDT 

NexgenRx:Completes private placement financing, pursuant to which it has issued an aggregate of 3,235,294 units at a price of $0.17 per Unit for aggregate gross proceeds of $550,000.Proceeds of this offering will be used to repay an interim shareholder demand loan that was recently obtained to facilitate the repayment of a previously issued $500,000 principal amount convertible debenture that was due June 12, 2015, as well as for general working capital purposes.  Full Article

NexgenRx Inc announces private placement financing
Monday, 15 Jun 2015 09:00am EDT 

NexgenRx Inc:Issued $500,000 principal amount convertible debenture due June 12, has been re-paid in full.Under the private placement, the Corporation expects to raise gross proceeds of $500,000 through the issuance of units at a price of $0.17 per unit.  Full Article

More From Around the Web

BRIEF-Nexgenrx Qtrly loss per share $0.175

* Nexgenrx announces Q3 2016 results Source text for Eikon: Further company coverage:

No consensus analysis data available.